Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-02-25 @ 7:02 PM
Study NCT ID:
NCT04823702
Status:
COMPLETED
Last Update Posted:
2022-01-19
First Post:
2021-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
Sponsor:
NGM Biopharmaceuticals, Inc
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Impaired Hepatic Function | View |
Keywords: